A carregar...

PARP Inhibitors for the Treatment and Prevention of Breast Cancer

Poly (ADP-ribose) polymerase (PARP) inhibitors, a novel class of drugs that target tumors with DNA repair defects, have received tremendous enthusiasm. Early preclinical studies identified BRCA1 and BRCA2 tumors to be highly sensitive to PARP inhibitors as a result of homologous recombination defect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vinayak, Shaveta, Ford, James M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3361972/
https://ncbi.nlm.nih.gov/pubmed/22655123
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!